Chemical Structure : T-1101 tosylate
CAS No.: 2250404-95-4
Catalog No.: PC-20310Not For Human Use, Lab Use Only.
T-1101 tosylate (TAI-95 tosylate) is a potent, orally abioavailable Hec1 inhibitor that disrupts Hec1-Nek2 protein interaction wide anti-cancer spectrum (GI50=14.29-73.65 nM, breast cancer cell lines).
Packing | Price | Stock | Quantity |
---|---|---|---|
5 mg | $58 | In stock | |
10 mg | $98 | In stock | |
25 mg | $158 | In stock | |
50 mg | $258 | In stock | |
100 mg | Get quote |
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
T-1101 tosylate (TAI-95 tosylate) is a potent, orally abioavailable Hec1 inhibitor that disrupts Hec1-Nek2 protein interaction wide anti-cancer spectrum (GI50=14.29-73.65 nM, breast cancer cell lines).
T-1101 tosylate demonstrates strong inhibition of in vivo tumor growth of breast cancer models without inducing weight loss or other obvious toxicity.
T-1101 tosylate induces apoptotic cell death, shows activity on MDR cell lines and leads to downregulation of the expression of P-glycoprotein (Pgp),.
T-1101 tosylate also increases the potency of cytotoxic Pgp substrates, including doxorubicin and topotecan.
T-1101 tosylate showed promise in antitumor activity in mice bearing human tumor xenografts of liver cancer (Huh-7), as well as of breast cancer (BT474, MDA-MB-231, and MCF7) with oral administration.
M.Wt | 665.80 | |
Formula | C31H31N5O6S3 | |
Appearance | Solid | |
Storage |
|
|
Solubility |
10 mM in DMSO |
|
Chemical Name/SMILES |
N-[4-(4-{[5-(2-methoxyethoxy)pyrazine-2-yl]thio}-2,6-dimethylphenyl) thiazol-2-yl]isonicotinamide tosylate |
1. Huang LY, et al. Mol Cancer Ther. 2014 Jun;13(6):1419-30.
2. Chuang SH, et al. Eur J Med Chem. 2020 Apr 1;191:112118.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright